Di Wu

army medical university

H指数:14

被引数:493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis

Dapk2功能障碍导致Mic60乳酸化及线粒体代谢重编程，促进肺癌EGFR-TKI耐药和转移

Developmental Cell

IF8.7

2025-08-130

PRE

Aminoguanidine-assembled functional DNA tetrahedron alleviates acute lung injury by targeting the cGAS-STING signaling pathway

Aminoguanidine-组装的功能性DNA四面体通过靶向cGAS-STING信号通路缓解急性肺损伤

MATERIALS TODAY BIO

IF10.2

2025-06-010

OAAI

Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China

中国ALK阳性非小细胞肺癌患者中洛拉替尼疗效和安全性的真实世界分析

FRONTIERS IN ONCOLOGY

IF3.3

2025-05-010

Anti-EGFR therapy can overcome acquired resistance to the third-generation ALK-tyrosine kinase inhibitor lorlatinib mediated by activation of EGFR

抗EGFR疗法可以克服由EGFR激活介导的第三代ALK酪氨酸激酶抑制剂lorlatinib所获得的耐药性。

ACTA PHARMACOLOGICA SINICA

IF8.4

2025-03-210

PRE

A novel technique of cryodenervation for murine vagus nerve: implications for acute lung inflammation

一种用于小鼠迷走神经的新型冷冻去神经术：对急性肺炎症的启示

RESPIRATORY RESEARCH

IF5

2025-01-130

Integrated ubiquitomics characterization of hepatocellular carcinomas

HEPATOLOGY

IF15.8

2024-09-300

PRE

A Chemotherapy-Photothermal synergistic system in bifunctional bone Scaffold: Tumor therapy and bone repair

MATERIALS & DESIGN

IF7.9

2024-09-010

OAAI

Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-08-110

OAAI

CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-08-010

OAAI

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

CANCER LETTERS

IF10.1

2024-04-013

PRE

Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer

布格替尼是一种新发现的AXL抑制剂，可抑制EGFR突变的非小细胞肺癌中AXL介导的对奥希替尼的获得性耐药

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-03-043

PRE

Rab26 promotes macrophage phagocytosis through regulation of MFN2 trafficking to mitochondria

FEBS JOURNAL

IF4.2

2023-05-157

PRE

Targeting Rab26 to Conquer Cisplatin-Resistant Lung Cancer with Self-Assembled DNA Nanomaterials

BIOMACROMOLECULES

IF5.4

2023-04-033

PRE

Attenuating endothelial leakiness with self-assembled DNA nanostructures for pulmonary arterial hypertension

用自组装DNA纳米结构减轻内皮细胞渗漏对肺动脉高压的影响

NANOSCALE HORIZONS

IF6.6

2023-01-013

Assembling defined DNA nanostructures with anticancer drugs: a metformin/DNA complex nanoplatform with a synergistic antitumor effect for KRAS-mutated lung cancer therapy

用抗癌药物组装定义的DNA纳米结构: 二甲双胍/DNA复合物纳米平台对KRAS突变的肺癌治疗具有协同抗肿瘤作用

NPG ASIA MATERIALS

IF8.3

2022-10-073

Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC

CELL DEATH DISCOVERY

IF7

2022-04-229

OAAI

Extracellular HMGB1 Impairs Macrophage-Mediated Efferocytosis by Suppressing the Rab43-Controlled Cell Surface Transport of CD91

细胞外HMGB1通过抑制CD91的Rab43-Controlled细胞表面转运来损害巨噬细胞介导的胞吞作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-2213

OAAI

An mTOR siRNA-Loaded Spermidine/DNA Tetrahedron Nanoplatform with a Synergistic Anti-Inflammatory Effect on Acute Lung Injury

负载mTOR siRNA的亚精胺/DNA四面体纳米平台对急性肺损伤具有协同抗炎作用

ADVANCED HEALTHCARE MATERIALS

IF9.6

2022-02-2523

PRE

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination

二甲双胍联合PD-1抑制剂通过AXIN-1-Dependent抑制STING泛素化增强STK11突变型肺癌的抗肿瘤疗效

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-02-2318

OAAI

Extracellular CIRP-Impaired Rab26 Restrains EPOR-Mediated Macrophage Polarization in Acute Lung Injury

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-12-0114

OAAI

Di Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向